Literature DB >> 17326191

Decreased hepatocyte membrane potential differences and GABAA-beta3 expression in human hepatocellular carcinoma.

Gerald Y Minuk1, Manna Zhang, Yuewen Gong, Leonard Minuk, Hans Dienes, Norman Pettigrew, Michael Kew, Jeremy Lipschitz, Dongfeng Sun.   

Abstract

UNLABELLED: To determine whether hepatocyte membrane potential differences (PDs) are depolarized in human HCC and whether depolarization is associated with changes in GABAA receptor expression, hepatocyte PDs and gamma-aminobutyric acid (GABA)A receptor messenger RNA (mRNA) and protein expression were documented in HCC tissues via microelectrode impalement, real-time reverse-transcriptase polymerase chain reaction, and Western blot analysis, respectively. HCC tissues were significantly depolarized (-19.8+/-1.3 versus -25.9+/-3.2 mV, respectively [P<0.05]), and GABAA-beta3 expression was down-regulated (GABAA-beta3 mRNA and protein expression in HCC; 5,693+/-1,385 and 0.29+/-0.11 versus 11,046+/-4,979 copies/100 mg RNA and 0.62+/-0.16 optical density in adjacent tumor tissues, respectively [P=0.002 and P<0.0001, respectively]) when compared with adjacent nontumor tissues. To determine the physiological relevance of the down-regulation, human malignant hepatocytes deficient in GABAA-beta3 receptor expression (Huh-7 cells) were transfected with GABAA-beta3 complementary DNA (cDNA) or vector alone and injected into nu/nu nude mice (n=16-17 group). Tumors developed after a mean (+/-SD) of 51+/-6 days (range: 41-60 days) in 7/16 (44%) mice injected with vector-transfected cells and 70+/-12 days (range: 59-86 days) in 4/17 (24%) mice injected with GABAA-beta3 cDNA-transfected cells (P<0.005).
CONCLUSION: The results of this study indicate that (1) human HCC tissues are depolarized compared with adjacent nontumor tissues, (2) hepatic GABAA-beta3 receptor expression is down-regulated in human HCC, and (3) restoration of GABAA-beta3 receptor expression results in attenuated in vivo tumor growth in nude mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17326191     DOI: 10.1002/hep.21562

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  18 in total

1.  GABA, γ-Aminobutyric Acid, Protects Against Severe Liver Injury.

Authors:  Toshiyuki Hata; Fatima Rehman; Tomohide Hori; Justin H Nguyen
Journal:  J Surg Res       Date:  2018-12-17       Impact factor: 2.192

Review 2.  Structure, function, and modulation of GABA(A) receptors.

Authors:  Erwin Sigel; Michael E Steinmann
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

3.  GABA stimulates human hepatocellular carcinoma growth through overexpressed GABAA receptor theta subunit.

Authors:  Yue-Hui Li; Yan Liu; Yan-Dong Li; Yan-Hong Liu; Feng Li; Qiang Ju; Ping-Li Xie; Guan-Cheng Li
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

Review 4.  GABAA receptors: structure, function, pharmacology, and related disorders.

Authors:  Amr Ghit; Dina Assal; Ahmed S Al-Shami; Diaa Eldin E Hussein
Journal:  J Genet Eng Biotechnol       Date:  2021-08-21

5.  Gamma-aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed gamma-aminobutyric acid A receptor alpha 3 subunit.

Authors:  Yan Liu; Yue-Hui Li; Feng-Jie Guo; Jia-Jia Wang; Rui-Li Sun; Jin-Yue Hu; Guan-Cheng Li
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

6.  Gamma-aminobutyric acid binds to GABAb receptor to inhibit cholangiocarcinoma cells growth via the JAK/STAT3 pathway.

Authors:  Qiang Huang; Cheng-Lin Zhu; Chen-Hai Liu; Fang Xie; Kai Zhu; San-Yuan Hu
Journal:  Dig Dis Sci       Date:  2012-09-25       Impact factor: 3.199

Review 7.  GABA's control of stem and cancer cell proliferation in adult neural and peripheral niches.

Authors:  Stephanie Z Young; Angélique Bordey
Journal:  Physiology (Bethesda)       Date:  2009-06

8.  The altered expression of α1 and β3 subunits of the gamma-aminobutyric acid A receptor is related to the hepatitis C virus infection.

Authors:  M Sidorkiewicz; M Brocka; M Bronis; M Grek; B Jozwiak; A Piekarska; J Bartkowiak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-13       Impact factor: 3.267

9.  Ex vivo nonviral gene delivery of μ-opioid receptor to attenuate cancer-induced pain.

Authors:  Seiichi Yamano; Chi T Viet; Dongmin Dang; Jisen Dai; Shigeru Hanatani; Tadahiro Takayama; Hironori Kasai; Kentaro Imamura; Ron Campbell; Yi Ye; John C Dolan; William Myung Kwon; Stefan D Schneider; Brian L Schmidt
Journal:  Pain       Date:  2017-02       Impact factor: 7.926

10.  Suppression of Human Liver Cancer Cell Migration and Invasion via the GABAA Receptor.

Authors:  Zhi-Ao Chen; Mei-Yan Bao; Yong-Fen Xu; Ruo-Peng Zha; Hai-Bing Shi; Tao-Yang Chen; Xiang-Huo He
Journal:  Cancer Biol Med       Date:  2012-06       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.